DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea
· Delayed Price · Currency is KRW
3,845.00
-25.00 (-0.65%)
At close: Dec 5, 2025
DK Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Debt / Equity Ratio | 0.29 | 0.43 | 0.49 | 0.46 | 0.28 | 0.07 | |
| Debt / EBITDA Ratio | 1.97 | 2.56 | 4.03 | 4.81 | 2.55 | 0.47 | |
| Debt / FCF Ratio | - | 7.01 | - | - | - | - | |
| Asset Turnover | 0.65 | 0.71 | 0.70 | 0.69 | 0.76 | 1.13 | |
| Inventory Turnover | 2.49 | 2.52 | 2.75 | 3.45 | 4.90 | 7.68 | |
| Quick Ratio | 1.30 | 1.11 | 0.98 | 1.09 | 1.03 | 1.57 | |
| Current Ratio | 1.80 | 1.84 | 1.62 | 1.72 | 1.46 | 1.91 | |
| Return on Equity (ROE) | 5.68% | 2.22% | 4.46% | 4.90% | 7.45% | 7.16% | |
| Return on Assets (ROA) | 4.02% | 4.02% | 3.10% | 2.49% | 3.16% | 5.41% | |
| Return on Capital (ROIC) | 5.09% | 5.05% | 3.86% | 3.27% | 4.58% | 7.83% | |
| Return on Capital Employed (ROCE) | 9.60% | 9.30% | 7.40% | 5.40% | 7.30% | 11.20% | |
| Buyback Yield / Dilution | 17.34% | -14.52% | -900.58% | -0.01% | 2.05% | -2.09% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.